Trial Profile
A study investigating the effect of bendamustine when given along with prednisone and bortezomib on stem cell mobilization and autologous stem cell transplantation in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Bortezomib; Prednisone
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.